The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
Open accessAbstract
Moloney Murine Leukemia Virus (MoMuLV) causes T cell neoplasms in rodents but is not known to be a pathogen in primates. The core protein and enzyme genes of the MoMuLV genome together with an amphotropic envelope gene are utilized to engineer the cell lines that generate retroviral vectors for use in current human gene therapy applications. We developed a producer clone that generates a very high concentration of retroviral vector particles to optimize conditions for gene insertion into pluripotent hematopoietic stem cells. This producer cell line also generates a much lower concentration of replication-competent virus that arose through recombination. Stem cells from rhesus monkeys were purified by immunoselection with an anti-CD34 antibody, incubated in vitro for 80-86 h in the presence of retroviral vector particles with accompanying replication-competent virus and used to reconstitute recipients whose bone marrow had been ablated by total body irradiation. The retroviral vector genome was detected in circulating cells of five of eight transplant recipients of CD34+ cells and in the circulating cells of two recipients of infected, unfractionated bone marrow mononuclear cells. Three recipients of CD34+ cells had a productive infection with replication-competent virus. Six or seven mo after transplantation, each of these animals developed a rapidly progressive T cell neoplasm involving the thymus, lymph nodes, liver, spleen, and bone marrow. Lymphoma cells contained 10-50 copies of the replication-competent virus, but lacked the retroviral vector genome. We conclude that replication-competent viruses arising from producer cells making retroviral vectors can be pathogenic in primates, which underscores the importance of carefully screening retroviral producer clones used in human trials to exclude contamination with replication-competent virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although viral vectors have been widely used in the delivery of the CRISPR/Cas9 system in vitro and in vivo, their fundamental shortcomings, such as the risk of carcinogenesis, limited insertion size, immune responses and difficulty in large-scale production, severely limit their further applications.”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,990
Mann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,776
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895-2902.1986 · Cited by 1,371
Granulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. D. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,066
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S. P., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,062
Danos, O., & Mulligan, R. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6460 · Cited by 898
Yang, Y., Ciarletta, A. B., Temple, P. A., Chung, M. P., Kovacic, S., Witek-Giannotti, J. S., Leary, A. C., Kriz, R., Donahue, R. E., Wong, G. G., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90360-0 · Cited by 766
Self-citationPrimary structure and functional expression of rat and human stem cell factor DNAs
Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I., Jacobsen, F. W., Mendlaz, E. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90301-t · Cited by 719
Cited by
Sorted by citations
Items 501–525 of 525
Gene Therapy Vectors: Safety Considerations
Bloom, E. T., Kuta, A. E., & Noguchi, P. D. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00586-4
Shimizu, S., Kamata, M., Kittipongdaja, P., Chen, K. N., Kim, S., Pang, S., Boyer, J., Qin, F. X.-F., An, D. S., Chen, I. S. Y., et al. (2009)
Aso, M., Yamamoto, T. T., Kuroda, M., Wada, J., Kubota, Y., Ishikawa, K., Maezawa, Y., Tawada, A., Asada, S., Aoyagi, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3915012
Retroviral Vectors and Gene Therapy
Gallo, R. C., & Reitz, M. S. (2003)
Vectors for Gene Therapy: Strategies for Making Gene Therapy Work
Onions, D. E. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2017-7_17
Rüger, R., & Seeber, S. (2003) · Springer eBooks · doi:10.1007/978-3-662-07588-3_17
Tanabe, K. K., & Cusack, J. C. (2001) · Springer eBooks · doi:10.1007/978-3-642-57282-1_86
Sastry, L., Xu, Y., Duffy, L., Koop, S., Jasti, A. C., Roehl, H., Jolly, D. J., & Cornetta, K. G. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-122
(2005) · Biotechnology Law Report · doi:10.1089/blr.2005.24.746
Tente, W. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00177-4
Orchard, P. J., & McIvor, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-383-5_14
Gene Marking Studies of Hematopoietic Cells
Heslop, H. E., Brenner, M. K., & Bollard, C. M. (2003) · CRC Press eBooks · doi:10.1201/9780824758608.ch44
Aso, M., Yamamoto, T. T., Kuroda, M., Wada, J., Kubota, Y., Ishikawa, K., Maezawa, Y., Tawada, A., Asada, S., Aoyagi, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3948386
Retroviruses in Human Gene Therapy
Pedersen, F. S., & Duch, M. (2005) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0003843
Parvovirus Vectors: The Future of Gene Therapy
Gupta, M. (2022) · Veterinary medicine and science · doi:10.5772/intechopen.105085
Gallo, R. C., & Reitz, M. S. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm028.pub2
Tashiro, H., Scherer, L. D., & Brenner, M. K. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm069.pub2
Gallo, R. C., & Reitz, M. S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm028
Cornetta, K. G., Lin, T., Tao, H., Huang, J., Piskorowski, J., Wilcox, P., Xie, D., Yao, J., House, K. D., Nance, E., et al. (2024) · Journal of Virological Methods · doi:10.1016/j.jviromet.2024.114988
Molekulare Grundlagen des Gentransfers und Anwendung für die Gentherapie
Brand, K., & Strauss, M. (1998) · Springer eBooks · doi:10.1007/978-3-642-80362-8_6
Gene Therapy for Nonneoplastic Hematologic and Histiocytic Disorders
Washington, K. N., Tisdale, J. F., & Hsieh, M. M. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_45
Tosun, M., & Schenerman, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21988-7.00028-1
Metadata
- Authors
- Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-10-01
- Volume
- 176
- Issue
- 4
- Pages
- 1125-1135
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2119385
- OpenAlex
- W2132859839
- Cited by
- 532
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2022: 8 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 10 · 2017: 7 · 2015: 8 · 2014: 11 · 2013: 5 · 2012: 9
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- Moloney murine leukemia virus, retroviral vectors, replication-competent virus, T-cell lymphoma, helper virus, retroviral gene transfer, CD34+ hematopoietic stem cells, bone marrow transplantation, rhesus monkeys, non-human primates, gene therapy safety, thymic lymphoma
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Differentiation, Base Sequence, Cells, Cultured, DNA, Neoplasm, DNA, Viral, Globins, Helper Viruses, Macaca mulatta, Molecular Sequence Data, Moloney murine leukemia virus, Oligodeoxyribonucleotides, Time Factors, Transfection, Virus Replication, Antigens, CD, Bone Marrow Transplantation, Lymphoma, T-Cell, Genome, Viral, Antigens, CD34
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
